Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients
SourceNuclear Medicine Communications, 16, (1995), pp. 853-859
Article / Letter to editor
Display more detailsDisplay less details
Obstetrics and Gynaecology
Nuclear Medicine Communications
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.